Metabolic effects of buflomedil hydrochloride.
Briguglio
F
F
Di Marco
V
V
Circosta
C
C
Padovano
I
I
Ragusa
S
S
Saija
A
A
Briguglio
E
E
D019794:2,3-Diphosphoglycerate; D000255:Adenosine Triphosphate / Q000097:blood; D000262:Adenylyl Cyclases / Q000097:blood; D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000097:blood; D002908:Chronic Disease; D000242:Cyclic AMP / Q000097:blood; D003925:Diabetic Angiopathies / Q000097:blood; D004163:Diphosphoglyceric Acids / Q000097:blood; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood; D008173:Lung Diseases, Obstructive / Q000097:blood; D008297:Male; D008875:Middle Aged; D010727:Phosphoric Diester Hydrolases / Q000097:blood; D011759:Pyrrolidines / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D004163:Diphosphoglyceric Acids; D011759:Pyrrolidines; D014665:Vasodilator Agents; D019794:2,3-Diphosphoglycerate; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000262:Adenylyl Cyclases; C010651:buflomedil